Ernexa Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.20

+0.01 (+7.57%)

As of Mar 31, 5:05 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +15,035.3% upside

Low Target $21.48

Average Target $30.77

High Target $35.71

Current Price $0.20

Current
$0.20

Target
$30.77

$21.48 $30.77 avg $35.71

Scenario Analysis

Bear Case

$21.48

10,465.7%

Low target

Base Case

$30.77

+15,035.3%

Avg target

Bull Case

$35.71

+17,465.2%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$4.02

-94.9% from high

52-Week Low

$0.20

+1.1% from low

Target vs 52W High

$30.77

+665.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%